Drug Use Investigation of Kovaltry in Hemophilia A Patients
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A
- Focus Adverse reactions
- Sponsors Bayer
- 04 Feb 2018 Planned number of patients changed from 200 to 30.
- 21 Dec 2016 Status changed from not yet recruiting to recruiting.
- 21 Nov 2016 Planned initiation date changed from 1 Oct 2016 to 1 Dec 2016.